Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7,632 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The combination of the neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as a novel predictor of intravenous immunoglobulin resistance in patients with Kawasaki disease: a multicenter study.
Kanai T, Takeshita S, Kawamura Y, Kinoshita K, Nakatani K, Iwashima S, Takizawa Y, Hirono K, Mori K, Yoshida Y, Nonoyama S. Kanai T, et al. Among authors: mori k. Heart Vessels. 2020 Oct;35(10):1463-1472. doi: 10.1007/s00380-020-01622-z. Epub 2020 May 24. Heart Vessels. 2020. PMID: 32449049
Circulating soluble selectins in Kawasaki disease.
Takeshita S, Dobashi H, Nakatani K, Koike Y, Tsujimoto H, Hirayama K, Kawamura Y, Mori K, Sekine I, Yoshioka S. Takeshita S, et al. Among authors: mori k. Clin Exp Immunol. 1997 Jun;108(3):446-50. doi: 10.1046/j.1365-2249.1997.3852128.x. Clin Exp Immunol. 1997. PMID: 9182890 Free PMC article.
Oncologic Outcomes of Endoscopic Management of Upper Tract Urothelial Carcinoma: A Systematic Review and Pooled Analysis from the EAU-YAU Urothelial Working Group.
Gallioli A, Uleri A, Verri P, Tedde A, Mertens LS, Moschini M, Del Giudice F, Soria F, Laukhtina E, Subiela JD, Krajewski W, D'Andrea D, Mari A, Marcq G, Mori K, Teoh J, Afferi L, Albisinni S, Sanguedolce F, Palou J, Breda A, Pradere B; EAU-YAU Urothelial Working Group. Gallioli A, et al. Among authors: mori k. Eur Urol Focus. 2025 Feb 1:S2405-4569(25)00009-4. doi: 10.1016/j.euf.2025.01.009. Online ahead of print. Eur Urol Focus. 2025. PMID: 39894734 Review.
Novel combination therapy for platinum-eligible patients with locally advanced or metastatic urothelial carcinoma: a systematic review and network meta-analysis.
Yanagisawa T, Mori K, Matsukawa A, Kawada T, Katayama S, Laukhtina E, Rajwa P, Quhal F, Pradere B, Fukuokaya W, Iwatani K, Pichler R, Teoh JY, Moschini M, Krajewski W, Miki J, Shariat SF, Kimura T; European Association of Urology–Young Academic Urologists Urothelial Carcinoma Working Group (EAU-YAU). Yanagisawa T, et al. Among authors: mori k. Cancer Immunol Immunother. 2025 Feb 1;74(3):76. doi: 10.1007/s00262-024-03910-3. Cancer Immunol Immunother. 2025. PMID: 39891702 Free PMC article. Review.
Association of body mass index and tumor response in metastatic urothelial carcinoma treated with enfortumab vedotin: data from the ULTRA-Japan consortium.
Uchimoto T, Iwatsuki K, Komura K, Fukuokaya W, Adachi T, Hirasawa Y, Hashimoto T, Yoshizawa A, Saruta M, Hashimoto M, Minami T, Yamamoto Y, Yamazaki S, Takai T, Sakamoto M, Nakajima Y, Nishimura K, Maenosono R, Tsujino T, Nakamura K, Fukushima T, Nishio K, Yoshikawa Y, Yamamoto S, Iwatani K, Urabe F, Mori K, Yanagisawa T, Tsuduki S, Takahara K, Fujita K, Kimura T, Ohno Y, Shiroki R, Azuma H. Uchimoto T, et al. Among authors: mori k. Int J Clin Oncol. 2025 Jan 31. doi: 10.1007/s10147-025-02709-1. Online ahead of print. Int J Clin Oncol. 2025. PMID: 39890750
7,632 results